adenosine monophosphate has been researched along with Mesothelioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Taei, S; Clayton, A; Mason, MD; Tabi, Z; Webber, J | 1 |
Fujita, Y; Fukuoka, K; Gotoh, A; Kanno, T; Nakano, T; Nishizaki, T; Nogi, Y; Tabata, C | 1 |
2 other study(ies) available for adenosine monophosphate and Mesothelioma
Article | Year |
---|---|
Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Antigens, CD; Apyrase; Caco-2 Cells; Cell Line, Tumor; Down-Regulation; Exosomes; GPI-Linked Proteins; Humans; Hydrolysis; Jurkat Cells; Mesothelioma; Phosphorylation; Pleural Neoplasms; T-Lymphocytes, Regulatory | 2011 |
AMP converted from intracellularly transported adenosine upregulates p53 expression to induce malignant pleural mesothelioma cell apoptosis.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Adenosine Monophosphate; Apoptosis; Apoptosis Inducing Factor; Apoptosis Regulatory Proteins; Caspases; Cell Line, Tumor; Cell Survival; GATA2 Transcription Factor; Gene Expression; Gene Knockdown Techniques; Humans; In Situ Nick-End Labeling; Mesothelioma; Mitochondrial Proteins; Pleural Neoplasms; Receptor, Adenosine A3; RNA Interference; Tumor Suppressor Protein p53; Up-Regulation | 2012 |